The equipment and experiments described here were funded by the Department of Cardiology, Boston Children&#39;s Hospital and by philanthropic donations from the Haseotes family. We are grateful to Drs. Frank McGowan and Huamei He for providing us with early experiences with this model, and to Lindsay Thomson for assistance with artwork.

This protocol is performed under a current protocol under the institution&#39;s animal care and use committee.
1. Preparation for the Study
<ol>
	<li>Turn on the water bath to heat the Krebs-Henseleit buffer (KHB) reservoir (set to 42 &#176;C).</li>
	<li>Prepare 16 L of KHB containing (in mM) 128 NaCl, 5.7 KCl, 1.3 MgSO4, 25 NaHCO3, 2.7 CaCl2, 0.53 EDTA, 0.54 NaC3H3O3, and 10.8 dextrose.13 The substrate masses are as follows: 27.584 g NaCl, 1.58 g&#160; KCl, 0.578 g MgSO4, 8.401 g NaHCO3, 1.47 g CaCl2, 0.744 g EDTA, 0.22 g NaC3H3O3, and 7.208 g dextrose. 
	Note: these components may be stored in conical tubes in powdered form for constitution on the day of experimentation.
	<ol>
		<li>Filter 4 L of deionized water through a 0.22 micron filter.</li>
		<li>Add 3.7 L of this water to a 4 L beaker. Add all components except for CaCl2 to the water.</li>
		<li>Dissolve the CaCl2 in the remaining 300 ml of water using a separate beaker.</li>
		<li>Oxygenate the solution with 95% O2 / 5% CO2 at 1 L/min (LPM) for 5 min. This corrects the pH to 7.40 and enhances dissolution of CaCl2.</li>
		<li>Add the CaCl2 to the remainder of the KHB.</li>
		<li>Add the completed KHB to a reservoir and circulate through all tubing for 30 min. Ensure that the system is free of macroscopic bubbles. Oxygenate with 95% O2 / 5% CO2 at 0.5 LPM. 
		NOTE: KHB may be stored overnight in the refrigerator for no more than 1 - 2 days, brought back to room temperature and re-filtered for use. Do not reuse KHB between experiments.</li>
		<li>Prepare 2 x 50 ml clean beakers with ice cold KHB and place them in a bucket of ice near the dissection station. Ensure that the KHB is ice cold (rather than chilled) before explanting the heart.</li>
		<li>Place the micro pressure-volume (PV) catheter in a 10 ml syringe filled with filtered KHB for 30 min prior to calibration, per manufacturer&#39;s instructions. 
		NOTE: Temperature of KHB used to soak the PV catheter should be as close to 37 &#176;C as possible.</li>
	</ol>
	</li>
	<li>Prepare the anesthesia and dissecting station for the animal.
	<ol>
		<li>Ensure adequate isoflurane in the reservoir. Draw up 500 U of heparin in a 1 ml syringe; place a 26 gauge (1/2&#34;) needle on this syringe. Prepare a mask for anesthetizing the animal.</li>
	</ol>
	</li>
	<li>Set the aortic block perfusion pressure to 80 mmHg and the left atrial (LA) block perfusion pressure to 10 mmHg. Open both the aortic block and LA block to allow warm KHB to drip out. When ready to dissect the animal, open the aortic block to allow a steady slow drip of KHB out.</li>
	<li>Calibrate the PV catheter according to manufacturers&#39; instructions.</li>
</ol>
2. Animal Preparation and Dissection
NOTE: For best results, ensure animal is between 300 and 500 g; we have found that an animal weight between 425 to 450 g is ideal for our system.
<ol>
	<li>Anesthetize the animal in a chamber using isoflurane (1 - 2%) until the animal is unconscious. Transfer the animal to the dissection station and place the anesthesia mask with isoflurane and oxygen on the animal. Perform toe pinch to assess level of sedation. Apply vet ointment on eyes to prevent dryness while under anesthesia.</li>
	<li>Inject heparin, 500 units intraperitoneal in the abdominal cavity. Allow 10 min for the Heparin to be absorbed. Secure the limbs of the animal with tape to enhance visualization of the thorax.</li>
	<li>Dissection of the heart.
	<ol>
		<li>Once ensuring that there is no response to a toe pinch, lift the skin away from the abdominal cavity with forceps and then use scissors to incise the peritoneal cavity, following the curve of the diaphragm back to the posterior angle of the ribs.</li>
		<li>Once the diaphragm is visible, using small scissors, cut along the anterior surface of the diaphragm following the direction of the prior cuts to allow for entry into the thorax. Extend each cut along the axillary line bilaterally to the axilla. 
		NOTE: The next steps should be performed efficiently since ventilation will be compromised once the diaphragm is incised.</li>
		<li>Retract the ribcage anteriorly from the xiphoid process using forceps. Incise the pericardium and pleura.</li>
		<li>Identify the inferior vena cava (IVC) and aorta just above the diaphragm and retract them en bloc anteriorly using blunt forceps.</li>
		<li>Using large, curved scissors, rapidly make an incision across the IVC and the aorta, pulling the heart and lungs out of the chest en bloc. Cut the esophagus, trachea, brachiocephalic arteries and veins cephalad to remove the heart and lungs from the thorax. Excise the thymic tissue with this block of tissue. Take care not to cut the proximal portion of the ascending aorta.</li>
		<li>Immediately immerse the heart and lungs in ice-cold KHB and move to the Langendorff apparatus, previously set up as described in step 1.</li>
	</ol>
	</li>
</ol>
3. Aortic Cannulation
<ol style="margin-left: 40px;">
	<li>Place the heart-lung complex in a flat dish and orient the heart with the thymus and great vessels facing the experimenter and the posterior aspect of the lungs facing the table. Pull apart the two lobes of the thymus and identify the takeoff of the brachiocephalic arteries from the aorta.
	<ol>
		<li>Drape the aorta over the edge of the dish and transect the aorta using small scissors approximately 5 mm above the aortic valve, just proximal to the takeoff of the right subclavian artery. 
		NOTE: The incision should yield a clean round circle &#8212; the aorta in cross-section. If it is off-angle (i.e., a wide oval) or incomplete, repeat the cut to achieve the desired result. This will facilitate efficient aortic cannulation.</li>
	</ol>
	</li>
	<li>Using 2 pairs of curved forceps on either side of the aorta, guide the aorta over the aortic cannula (which should be slowly dripping with KHB). The aortic valve should sit 1 - 2 mm below the tip of the cannula.
	<ol>
		<li>After aorta cannulation, reposition the forceps perpendicularly across the aorta to hold the aorta in place. Alternatively, place a small clamp across the aorta to hold the heart lung complex in place, enabling a single experimenter to complete this model.</li>
	</ol>
	</li>
	<li>Have an assistant pass a silk 4-0 suture just below the forceps and tie into place, looping around the cannula and tying multiple times both in front of and behind the heart. Open the cannula fully to begin full retrograde aortic flow. Observe the heart beat vigorously. 
	NOTE: If the heart does not begin to beat rapidly (~ 200 BPM) and vigorously, the tie or cannula may be occluding one or both of the coronary arteries. If this is suspected, remove the tie and reposition it away from the coronary arteries. If the heart distends and does not beat, the cannula may be across the aortic valve. If the coronary artery leaks (KHB sprays from the aortic root), advance the cannula closer to the aortic valve (this phenomenon can occur if a brachiocephalic artery is cannulate in place of the ascending aorta).</li>
</ol>
4. Pulmonary Vein Occlusion and Preparation of the Pulmonary Artery for Cannulation
NOTE: The purpose of this step is to create a closed left atrial system to ensure that all volume and pressure from the left atrial block is transmitted to the left heart structures. Failure to completely occlude the pulmonary veins could result in preload deficiency and may falsify results or create an unstable working heart preparation.
<ol>
	<li>Remove the thymus to improve exposure of the pulmonary artery (PA).</li>
	<li>Manually rotate the aortic cannula so that the posterior aspect of the heart is facing the operator. Dissect out the vessels leading to the right lung. Suspend the right lung tissue using forceps to further delineate these vessels. Using medium-large surgical clips (or suture), occlude the right pulmonary artery and vein and bronchus with a single clip. Resect the right lung distal to the clip. 
	NOTE: Due to difficulty in dissecting the pulmonary artery free, our practice is to occlude the pulmonary veins to distend the pulmonary artery, making it easier to incise without injuring the nearby structures in a beating heart model.</li>
	<li>Repeat step 4.2 on the left lung. 
	NOTE: Potential pitfalls and problem solving: Once both pulmonary arteries are occluded, the right atrium will visibly distend and the heart may become bradycardic. This is because the right ventricle becomes pressurized. If this does not occur, it is likely that the pulmonary veins are not completely occluded, and that preload will be insufficient for working heart mode. If the heart is not able to maintain cardiac output after left atrial (LA) cannulation and attempted transition to working heart (see below), consider placing additional clips or a tie around the pulmonary vein stumps to occlude any residual leak. Once the PAs are occluded, however, Step 5 should be performed immediately to minimize myocardial ischemia. Note that some investigators incise the pulmonary artery prior to ligation of the pulmonary veins to avoid pressurization of the right ventricle.</li>
	<li>Pulmonary arterial incision
	<ol>
		<li>Rotate the aortic cannula so that the anterior aspect of the heart is facing the operator. Identify the pulmonary artery. Again, this artery may be distended. Using small scissors make a transverse incision approximately 3 mm above the pulmonary valve. 
		NOTE: This will immediately relieve the pressure and the heart rate may increase. Because this cannula is easy to dislodge, cannulate the pulmonary artery after left atrial cannulation is complete.</li>
	</ol>
	</li>
</ol>
5. Left Atrial Cannulation
<ol>
	<li>Rotate the aortic cannula so that the left atrium is facing the operator. Using the small scissors, make a 2 - 3 mm incision in the upper body of the left atrium, approximately 3 mm above the atrioventricular groove.
	<ol>
		<li>Position the left atrial cannula perpendicular to the plane of the mitral valve and pointed towards the atrial septum.</li>
		<li>Open the LA cannula until KHB flows. Ensure that the KHB is warm to the touch (it gets cold quickly when sitting in any non-jacketed tubing) in order to avoid myocardial dysfunction due to hypothermia following transition to working mode. Transition to a drip rate during cannulation.</li>
	</ol>
	</li>
	<li>Using forceps to hold counter-traction, insert the atrial cannula into the body of the left atrium, taking care not to use excessive force, which can tear the atrium. 
	NOTE: The LA cannula should be positioned so that it sits in the middle of the atrium without any tension on the atrial wall.</li>
	<li>Pass a 4-0 silk suture around body of the left atrium and tie a knot to create a seal of the atrium around the cannula. Take care to ensure that the posterior aspect of the left atrium is included in the suture. Add additional sutures as necessary. Once sealed, pull the cannula back 1 - 2 mm so that it sits in the middle of the atrium rather than against the atrial septum. 
	NOTE: The most common reason that the heart becomes malperfused upon transition to working heart mode is that the LA cannula abuts the atrial septum, which occludes left atrial inflow. The LA tracing often changes to demonstrate a proper a wave and v wave when the cannula is in proper position (see Figure 2E).</li>
	<li>Open the LA cannula valve entirely to administer the full preload to the left atrium. Monitor the drip rate from the heart (which comes from coronary effluent). Ensure that the drip rate does not change when the LA cannula is open. If it does, retie the atrium around the cannula as described in step 6.4, as this represents a leak in the system.</li>
</ol>
6. Pulmonary Artery Cannulation and Transition to Working Heart Mode
<ol>
	<li>If measuring myocardial oxygen consumption (or other substances in coronary effluent, such as drug levels or cytokines), insert 1/32&#34; flexible tubing into the prior incision in the pulmonary artery. 
	NOTE: Oxygen consumption is measured as the difference in oxygen content between left atrial perfusate and pulmonary artery effluent.2
	<ol>
		<li>For continuous measurement of myocardial oxygen consumption, use an in-line oxygen electrode to compare left atrial and coronary sinus effluent.</li>
		<li>Collect coronary sinus effluent (from both the pulmonary artery and dripping from the heart) in a graduated cylinder for timed quantification of coronary flow.</li>
		<li>Calculate myocardial oxygen consumption as previously described. 2</li>
	</ol>
	</li>
	<li>Transition to working heart mode by turning off the retrograde aortic pump. 
	NOTE: When this is done, the LA pressure becomes the pre-load pressure and the resistor which was previously providing resistance to the retrograde pump in Langendorff mode now provides resistance to cardiac output, creating a mean arterial pressure. If the mean arterial pressure declines below ~ 80 mmHg, the cause is likely related to either preload or myocardial function. The most likely problem is the left atrial cannula, which should be adjusted after restarting the retrograde pump.</li>
</ol>
7. Insertion of the Left Ventricular Pressure Volume Catheter
NOTE: The PV catheter may be placed either retrograde (through the aortic valve) or via apical puncture. The benefit of retrograde is that position is more consistent and it obviates the need for apical puncture and the concomitant risks of coronary injury or loss of preload. However, retrograde placement can sometimes be very challenging, so we describe both techniques herein.
<ol>
	<li>Attach a 1.4 French pressure-volume catheter to the pressure volume loop system. Calibrate the system in warm KHB according to manufacturer&#39;s instructions. Ensure the waveform is visible in real time. Bring the catheter and cables close to the surface of the LV so as not to dislodge it following placement.</li>
	<li>For retrograde placement, open the adjustable valve and feed the PV catheter gently across the aortic valve until a stable pressure and volume waveform are identified. Avoid excessive use of force which can damage the aortic valve or puncture the ventricular apex. 
	NOTE: We have found that it is important to minimize the length of tubing and number of turns that the PV catheter must navigate to approach the AV. It may be helpful to cut down the tubing which comes with the system.</li>
	<li>For apical placement, use a 24 G angio-catheter to create an apical puncture in the LV. Make sure to avoid the left anterior descending coronary artery. Aim the needle towards the aortic valve from the ventricular apex. Advance the pressure-volume catheter into the body of the LV. Stop advancing the catheter as soon as the LV pressure and volume waveform is identified.</li>
	<li>Once the pressure-volume catheter is in place, move the water jacket into position around the heart. Secure the catheter to the wall of the water jacket with a small piece of tape.</li>
	<li>Ensure at least a 30 min period of stability prior to beginning any measurements or interventions.</li>
</ol>
8. Infusion of Medication
<ol>
	<li>(Optional) Infuse medications (e.g., dopamine) into the left atrial block using a standard medication pump. 
	NOTE: We have dosed medications according to the whole animal body weight since flow equivalent to a whole cardiac output passes through the atrial block; only a small portion of this passes through the coronary circulation, as it does in vivo. Alternatively, a second set of perfusate can be created with a preset concentration of medication and used to perfuse the heart. 
	NOTE: In our protocol, we infuse medications over a 12 min period, collecting physiologic data during the final 10 min of each infusion and comparing it to an immediately preceding 10 min baseline.</li>
</ol>
9. Physiologic Manipulations
<ol>
	<li>Heart rate
	<ol>
		<li>(Optional) suture two pacing wires onto the right atrial wall and attach to a temporary pacing device. 
		NOTE: This permits precise control of the heart rate (above the native sinus rate) and an understanding of the relationship between heart rate and contractility independent of a cardiotonic medication.</li>
	</ol>
	</li>
	<li>Preload
	<ol>
		<li>Vary the preload (defined as left ventricular end diastolic volume) by varying the height of the column feeding the left atrial block.</li>
	</ol>
	</li>
	<li>Blood pressure
	<ol>
		<li>Manipulate the blood pressure (the primary determinant of afterload in this model) using the pressure valves on the IH-51.</li>
	</ol>
	</li>
	<li>Coronary oxygen content
	<ol>
		<li>Accomplish varying degrees of myocardial hypoxia by perfusing the heart with KHB saturated in various gas mixtures. Do this by using separate jacketed reservoirs (each with its own gas mixture) to ensure equilibrium between the gas and KHB.</li>
		<li>Accomplish coronary ischemia by suture ligating a distal coronary artery. 
		NOTE: The ligation of proximal coronary arteries in the working heart mode can result in lethal myocardial dysfunction.</li>
		<li>Induce global coronary ischemia by interrupting or delaying retrograde perfusion for a defined period of time.</li>
	</ol>
	</li>
</ol>

<ol><li>Langendorff, O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Untersuchungen+am+uberlebenden+saugethierherzen+%5Binvestigations+on+the+surviving+mammalian+heart%5BTitle%5D)+AND+%22Arch+Ges+Physiol%22%5BJournal%5D)">Untersuchungen am uberlebenden saugethierherzen [investigations on the surviving mammalian heart.</a> Arch Ges Physiol. 61, 291-332 (1895).</li>
<li>Neely, J. R., Liebermeister, H., Battersby, E. J., Morgan, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Effect+of+pressure+development+on+oxygen+consumption+by+isolated+rat+heart%5BTitle%5D)+AND+%22Am+J+Physiol%22%5BJournal%5D)">Effect of pressure development on oxygen consumption by isolated rat heart.</a> Am J Physiol. 212 (4), 804-814 (1967).</li>
<li>Friehs, I., Cao-Danh, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Adenosine+prevents+protein+kinase+C+activation+during+hypothermic+ischemia%5BTitle%5D)+AND+%22Circ%22%5BJournal%5D)">Adenosine prevents protein kinase C activation during hypothermic ischemia.</a> Circ. 96 (9 Suppl), 221-226 (1997).</li>
<li>Aoyagi, T., Higa, J. K., Aoyagi, H., Yorichika, N., Shimada, B. K., Matsui, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cardiac+mTOR+rescues+the+detrimental+effects+of+diet-induced+obesity+in+the+heart+after+ischemia-reperfusion%5BTitle%5D)+AND+%22Am+J+Physio.+Heart+Circ+Physiol%22%5BJournal%5D)">Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.</a> Am J Physio. Heart Circ Physiol. 308 (12), H1530-H1539 (2015).</li>
<li>Kitahori, K., He, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Development+of+left+ventricular+diastolic+dysfunction+with+preservation+of+ejection+fraction+during+progression+of+infant+right+ventricular+hypertrophy%5BTitle%5D)+AND+%22Circ+Heart+Fail%22%5BJournal%5D)">Development of left ventricular diastolic dysfunction with preservation of ejection fraction during progression of infant right ventricular hypertrophy.</a> Circ Heart Fail. 2 (6), 599-607 (2009).</li>
<li>Cowan, D. B., Noria, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lipopolysaccharide+internalization+activates+endotoxin-dependent+signal+transduction+in+cardiomyocytes%5BTitle%5D)+AND+%22Circ+Res%22%5BJournal%5D)">Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes.</a> Circ Res. 88 (5), 491-498 (2001).</li>
<li>Broadley, K. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+analysis+of+the+coronary+vascular+responses+to+catecholamines%2C+using+a+modified+Langendorff+heart+preparation%5BTitle%5D)+AND+%22Br+J+Pharmacol%22%5BJournal%5D)">An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation.</a> Br J Pharmacol. 40 (4), 617-629 (1970).</li>
<li>Schmidt, H. D., Hoppe, H., Heidenreich, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Direct+effects+of+dopamine%2C+orciprenaline+and+norepinephrine+on+the+right+and+left+ventricle+of+isolated+canine+hearts%5BTitle%5D)+AND+%22Cardiol%22%5BJournal%5D)">Direct effects of dopamine, orciprenaline and norepinephrine on the right and left ventricle of isolated canine hearts.</a> Cardiol. 64 (3), 133-148 (1979).</li>
<li>Fawaz, G., Tutunjini, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+effect+of+adrenaline+and+noradrenaline+on+the+metabolism+and+performance+of+the+isolated+dog+heart%5BTitle%5D)+AND+%22Br+J+Pharm+Chemother%22%5BJournal%5D)">The effect of adrenaline and noradrenaline on the metabolism and performance of the isolated dog heart.</a> Br J Pharm Chemother. 15, 389-395 (1960).</li>
<li>Allen, L. A., Fonarow, G. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hospital+variation+in+intravenous+inotrope+use+for+patients+hospitalized+with+heart+failure%3A+insights+from+Get+With+The+Guidelines%5BTitle%5D)+AND+%22Circ+Heart+Fail%22%5BJournal%5D)">Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.</a> Circ Heart Fail. 7 (2), 251-260 (2014).</li>
<li>Furnival, C. M., Linden, R. J., Snow, H. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+inotropic+and+chronotropic+effects+of+catecholamines+on+the+dog+heart%5BTitle%5D)+AND+%22J+Physiol%22%5BJournal%5D)">The inotropic and chronotropic effects of catecholamines on the dog heart.</a> J Physiol. 214 (1), 15-28 (1971).</li>
<li>Li, J., Li, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Adverse+effects+of+dopamine+on+systemic+hemodynamic+status+and+oxygen+transport+in+neonates+after+the+Norwood+procedure%5BTitle%5D)+AND+%22J+Am+Coll+Cardiol%22%5BJournal%5D)">Adverse effects of dopamine on systemic hemodynamic status and oxygen transport in neonates after the Norwood procedure.</a> J Am Coll Cardiol. 48 (9), 1859-1864 (2006).</li>
<li>Gillis, A. M., Kulisz, E., Mathison, H. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cardiac+electrophysiological+variables+in+blood-perfused+and+buffer-perfused%2C+isolated%2C+working+rabbit+heart%5BTitle%5D)+AND+%22Am+J+Physiol%22%5BJournal%5D)">Cardiac electrophysiological variables in blood-perfused and buffer-perfused, isolated, working rabbit heart.</a> Am J Physiol. 271 (2 Pt 2), H784-H789 (1996).</li>
<li>Asfour, H., Wengrowski, A. M., Jaimes, R., Swift, L. M., Kay, M. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((NADH+fluorescence+imaging+of+isolated+biventricular+working+rabbit+hearts%5BTitle%5D)+AND+%22J+Vis+Exp%22%5BJournal%5D)">NADH fluorescence imaging of isolated biventricular working rabbit hearts.</a> J Vis Exp. (65), (2012).</li>
<li>Demmy, T. L., Magovern, G. J., Kao, R. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isolated+biventricular+working+rat+heart+preparation%5BTitle%5D)+AND+%22Ann+Thor+Surg%22%5BJournal%5D)">Isolated biventricular working rat heart preparation.</a> Ann Thor Surg. 54 (5), 915-920 (1992).</li>
</ol>

The authors have nothing to disclose.

This working heart model enables assessment of ventricular performance with full control of ventricular preload and afterload, oxygen tension of the perfusate, as well as heart rate. Among other factors, it permits assessment of the intrinsic myocardial effects of inotropic medications independent of afterload and preload, which ways that are not possible using an in vivo model. Because this model utilizes a crystalloid perfusate, it permits assessment the myocardium without interference from hemoglobin, simplifying spectroscopic analysis of myocardial energy states, for example.14 In this model, the right atrium is not cannulated as part of our instrumentation, though it is possible to do so. We intentionally chose not to do so in order to facilitate sampling of coronary sinus flow for the assessment of myocardial oxygen consumption. Importantly, though, the right heart still performs pressure and volume work in this model as it pumps the coronary sinus flow into the pulmonary artery cannula. Providing some right ventricular preload improves positioning of the ventricular septum and enhances left ventricular performance, and is an important component of this model.15
There are several experimental pitfalls to mention. The first is the initial retrograde cannulation, which should be performed expediently (i.e., in less than 2 min) to minimize the period of ischemia. The most important skill to master is the efficient isolation, preparation and handling of the ascending aorta. It is important that the aortic stump not be cut excessively short, leaving insufficient room for cannulation above the aortic valve. However, it is also important that the aortic stump not be too long, which can cause torqueing of the aorta around the cannula. It is also important that the aorta cannula and aortic root be appropriately size-matched. An excessively large aorta on a small cannula can also lead to torqueing of the aortic root on the cannula. The right subclavian artery typically takes off from the ascending aorta approximately 7 mm above the aortic valve. Identifying the brachiocephalic vessels (approximately 1 mm in diameter) during dissection and trimming of the aorta serve as important landmarks for the transverse aortic incision. Trimming the aorta just below the takeoff of the first brachiocephalic artery is advisable. Inclusion of this vessel in the trimmed aortic root typically leads to a leakage of KHB, and loss of aortic root pressure upon transitioning into working heart mode.
Another technically challenging aspect of cannulation is the left atrial cannulation. Although it is feasible to cannulate the left atrial appendage, we found that the cannula frequently gets stuck within the appendage, and does not pass easily into the body of the left atrium. Thus, we prefer to make the incision in the body of the left atrium, approximately 2 mm superior to the atrioventricular groove. It is important to position the left atrial cannula in the proper plane before insertion in order to avoid tearing the thin-walled atrium when securing the cannula.
We found that the ideal size of the left atrium incision was approximately 3 mm. Creating too small of an incision may also make the placement of the left atrial cannula more difficult, and may lead to tearing of the left atrium. We use a straight, 8 mm, beveled piece of oxygen-impermeable tubing (inner diameter 2.9 mm) on the left atrial block. We have found that using this, rather than a cannula with a beveled edge, leads to most consistent atrial cannulation and facilitates the process of securing the left atrial block. Regardless of the tubing used, it is important to ensure that the end of the tubing is not occluded by the atrial septum or the mitral valve (as depicted above, we found that the left atrial pressure tracing was helpful in this regard), as even subtle movement of the atrial cannula can significantly alter left ventricular preload and resulting hemodynamic measurements. For the same reason, it is important to ensure that the left atrium does not leak following after opening the left atrial block. It is important regardless of the type of tubing used to ensure that the tubing within this system is oxygen impermeable to ensure adequate oxygen delivery to the heart.
Another technically challenging aspect of the procedure was the placement of the pressure-volume (PV) catheter. We initially favored a retrograde placement of the catheter through the aortic block. Though technically feasible, we found it to be much simpler and expedient to place the PV catheter via transapical puncture. Care must be taken to monitor the position of the catheter throughout the duration of the experiment, as at times the catheter may move in or out of the left ventricle. This can be done by monitoring the pressure and volume tracings over time.
Finally, care should be taken to ensure that KHB solution is created fresh for each experiment. It is possible to weigh out the constituents of KHB and store them in conical tubes in powdered form ahead of time. On the day of experimentation, these may be mixed with sterile, filtered water, carbon dioxide/oxygen, and then calcium added to the mixture. It is also important to wash the system with enzyme active powdered detergent such as Tergazyme (or similar) and replace the perfusate filter regularly.
Several limitations of this experimental preparation should be noted. First, similar to all crystalloid-perfused Langendorff preparations, KHB and other asanguinous perfusates have a significantly diminished oxygen carrying capacity relative to blood. Although this is partially compensated for through coronary vasodilation and supraphysiologic coronary flow, the preparation is not entirely physiologic for this reason. Second, because of the nearly infinite compliance of the Windkessel chamber used in this instrument, the systolic and diastolic pressures are only minimally separated (see Figure 2A) and thus the coronary perfusion pressure is non-physiologic. This may be overcome in future models by incorporating an elastance component to the afterload block. Third, as with all isolated heart preparations, the heart undergoes a defined period (2 - 3 min) of warm ischemia which is likely to create myocardial injury or dysfunction. Minimizing this injury through practice of the technique is of utmost importance to representative results. Further, although necessary for animal welfare, inhaled anesthetics may serve as a myocardial suppressant early in the reperfusion process, though it is expected that this effect is quickly abolished as the heart is reperfused with KHB.
The working heart system described allows for a wide variety of physiologic investigations relevant to patient care, research and teaching. With a few additional modifications, the system can also be used to simulate important physiology relevant to congenital heart disease, including pulmonary hypertension and single ventricle physiology. Limitations include that it is an ex vivo preparation, that the heart is being perfused by a buffer instead of a higher-oxygen content blood.

The study of isolated organs permits control of physiologic conditions beyond what is possible in vivo. Ex vivo heart preparations were first described by Otto Langendorff,1 who described an isolated model with retrograde perfusion. Subsequently, others described the &#34;working heart&#34; model, in which the myocardium performs both pressure and volume work.2 Such preparations have been instrumental in elucidating mechanisms of myocardial action,3 myocardial metabolism,4-6 and effects of cardiotonic medications.7-9
The use of medications that enhance myocardial contractility is common in critically ill patients. However, few data are available comparing the relative effects of these medications on contractility and myocardial oxygen consumption, data which may be useful in the care of patients with clinical signs of heart failure of in the postoperative setting.10 However, because most cardiotonic medications affect not only the myocardium, but also arteriolar resistance, venous capacitance11, and a patient&#39;s metabolic rate,12 ex vivo isolated heart models remain the optimal means by which to study the effects of such medications on the myocardium proper.
We describe the use of an ex vivo model for the load-independent study of inotropic medications on myocardial function and oxygen consumption. Hearts from Sprague Dawley rats were cannulated using a left ventricular working heart model and perfused using a modified Krebs Henseleit perfusate. Aortic and left atrial pressures were controlled. Pressure-volume impedance catheters were placed into the left ventricle via apical puncture for the continuous monitoring of systolic and diastolic function. Oxygen consumption was continuously measured as the indexed difference in oxygen content between left atrial perfusate and the pulmonary artery effluent. Medications to be tested were infused into the left atrial block, and changes in cardiac performance and oxygen metabolism were measured and compared with an immediately preceding baseline.

<table><tbody><tr><td>Sodium bicarbonate</td><td>Sigma-Aldrich</td><td>S5761</td><td>8.401 g/4 L</td></tr><tr><td>Ethylenediaminetetraacetic acid</td><td>Sigma-Aldrich</td><td>E6758</td><td>0.744 g/4 L</td></tr><tr><td>Potassium chloride</td><td>Sigma-Aldrich</td><td>P9333</td><td>1.580 g/4 L</td></tr><tr><td>Magnesium sulfate</td><td>Sigma-Aldrich</td><td>M7506</td><td>0.578 g/4 L</td></tr><tr><td>Sodium pyruvate</td><td>Sigma-Aldrich</td><td>P2256</td><td>0.220 g/ 4 L</td></tr><tr><td>Sodium chloride</td><td>Sigma-Aldrich</td><td>S3014</td><td>27.584 g/4 L</td></tr><tr><td>Dextrose</td><td>Sigma-Aldrich</td><td>D9434</td><td>7.208 g/4 L</td></tr><tr><td>Calcium chloride dihydrate</td><td>Sigma-Aldrich</td><td>C7902</td><td>1.470 g/4 L</td></tr><tr><td>Biventricular working heart model</td><td>Harvard Apparatus</td><td>IH-51</td><td></td></tr><tr><td>Pressure volume catheter</td><td>Millar, Inc</td><td>SPR-944-1</td><td>6 mm spacing catheter used</td></tr><tr><td>LabChart Pro 8</td><td>AD Instruments</td><td>Version 8.1</td><td></td></tr></tbody></table>

rodent working heart model for the study of myocardial performance and oxygen consumption

Isolated working heart models have been used to understand the effects of loading conditions, heart rate and medications on myocardial performance in ways that cannot be accomplished in vivo. For example, inotropic medications commonly also affect preload and afterload, precluding load-independent assessments of their myocardial effects in vivo. Additionally, this model allows for sampling of coronary sinus effluent without contamination from systemic venous return, permitting assessment of myocardial oxygen consumption. Further, the advent of miniaturized pressure-volume catheters has allowed for the precise quantification of markers of both systolic and diastolic performance. We describe a model in which the left ventricle can be studied while performing both volume and pressure work under controlled conditions. 
In this technique, the heart and lungs of a Sprague-Dawley rat (weight 300-500 g) are removed en bloc under general anesthesia. The aorta is dissected free and cannulated for retrograde perfusion with oxygenated Krebs buffer. The pulmonary arteries and veins are ligated and the lungs removed from the preparation. The left atrium is then incised and cannulated using a separate venous cannula, attached to a preload block. Once this is determined to be leak-free, the left heart is loaded and retrograde perfusion stopped, creating the working heart model. The pulmonary artery is incised and cannulated for collection of coronary effluent and determination of myocardial oxygen consumption. A pressure-volume catheter is placed into the left ventricle either retrograde or through apical puncture. If desired, atrial pacing wires can be placed for more precise control of heart rate. This model allows for precise control of preload (using a left atrial pressure block), afterload (using an afterload block), heart rate (using pacing wires) and oxygen tension (using oxygen mixtures within the perfusate).

A schematic of a fully instrumented heart in retrograde perfusion (Figure 1A) and in left ventricular working heart (Figure 1B). Typical aortic, left atrial and left ventricular pressure and volume tracings are shown in Figure 2A - D. The typical end diastolic pressure is approximately 3 - 5 mmHg in this model, and the peak systolic pressure is approximately 100 mmHg. Figure 2E demonstrates the change in left atrial tracing when the LA cannula is moved away from the atrial septum during placement and positioning of the cannula. In these experiments, aortic pressure was set at 90 mmHg, and LA pressure was set to 10 mmHg.
To test the effects of catecholamines, each physiologic parameter (derived primarily from the pressure-volume catheter and associated software) was compared to the immediately preceding baseline period. In the example shown, dopamine was infused at 15 &#956;g/kg/min into the left atrial block. Although the end diastolic pressure is identical in the two conditions (given the fixed atrial pressure in this model), the left ventricular end diastolic volume decreases by 2.5%, and the left ventricular end systolic volume decreases by 4.9%, yielding an increased stroke volume (Figure 3A). Compared with placebo infusions, the left ventricular stroke work, identified as the area within the pressure-volume curve, increased by 32% during treatment with dopamine (Figure 3B, P &#60; 0.001, t test, n = 10 per group). This was associated with a greater increase in myocardial oxygen consumption relative to placebo infusions (Figure 3C). In this way, the relative potency and energy costs of different cardiotonic medications and doses can be compared to one another independent of their effects on loading conditions.
<img alt="Figure 1" src="/files/ftp_upload/54149/54149fig1.jpg" /> 
Figure 1: Diagram of Flow in a Fully Instrumented Heart in Retrograde Perfusion and Working Heart Mode. (Panel A: Langendorff mode; Panel B: working heart mode. In retrograde mode, KHB is infused at a set perfusion pressure into the aortic root. This mode is utilized to recover the myocardium following ischemic time and during instrumentation. In working heart mode, perfusate flows through the left heart before perfusing the coronary circulation. In this mode, the myocardium must generate its own perfusion pressure. <a href="https://www.jove.com/files/ftp_upload/54149/54149fig1large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" src="/files/ftp_upload/54149/54149fig2.jpg" /> 
Figure 2: Representative Pressure and Volume Tracings Obtained during Baseline Measurements. (A) Aortic root pressure, (B) left atrial pressure, (C) left ventricular pressure and (D) left ventricular volume tracings during a baseline measurement are displayed. Stroke volume, stroke work, cardiac output, tau, and other parameters can be automatically calculated and displayed in real-time by the software. A blunted left atrial tracing (E) associated with a poor cardiac output in working heart mode can be a clue that the cannula is malpositioned in the left atrium. Note that the prominent v wave in the well-placed left atrial pressure tracing is common, likely due to a decreased left atrial compliance in the fully instrumented animal. <a href="https://www.jove.com/files/ftp_upload/54149/54149fig2large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" src="/files/ftp_upload/54149/54149fig3.jpg" /> 
Figure 3: Effect of Dopamine on the Pressure-Volume Curve. Dopamine infusion results in a leftward shift in the PV curve (A), including an increased stroke volume, decreased end systolic volume, compared with baseline measurements. Note that the shape of some components of these PV curves differ from those typically measured in vivo (see Figure 4) due to the absence of arterial and venous elastance. (B) Relative to an immediately preceding baseline, stroke work increased significantly more during infusions of dopamine than placebo (**, P = 0.0017, t-test), as did myocardial oxygen consumption (*, P = 0.013, t-test, C). Using this model, the average myocardial oxygen consumption at baseline was 0.22 &#177; 0.02 mmol O2/gram tissue/minute, using an estimated dissolved oxygen content of 165 &#181;mol/L in saline at 40 &#176;C. Such measurements can be used to compare the myocardial oxygen consumption of various medications. <a href="https://www.jove.com/files/ftp_upload/54149/54149fig3large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" src="/files/ftp_upload/54149/54149fig4.jpg" /> 
Figure 4: Analysis of Pressure Volume Loops. The Theoretical Pressure-Volume Loop Shown Describes the Normal Cardiac Cycle. Following aortic valve (AV) closure (1), isovolemic contraction occurs (1 - 2) as ventricular pressure decreases below atrial pressure. The duration of this phase is represented by Tau. The mitral valve (MV) then opens contemporaneously with atrial systole, filling the ventricle (2 - 3). Systole then commences with isovolemic contraction (3 - 4) until ventricular pressure exceeds diastolic arterial pressure, at which time the AV opens. Stroke volume is the difference between lines 1 - 2 and 3 - 4. Stroke work is the area within the 1 - 2 - 3 - 4 curve. <a href="https://www.jove.com/files/ftp_upload/54149/54149fig4large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>

Watch this Scientific Journal Video about Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption at JoVE.com

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption

Isolated working heart models can be used to measure the effect of loading conditions, heart rate, and medications on myocardial performance and oxygen consumption. We describe methods for preparation of a rodent left heart working model that permits study of systolic and diastolic performance and oxygen consumption under various conditions.

Isolated working heart models have been used to understand the effects of loading conditions, heart rate and medications on myocardial performance in ways ...

rodent-working-heart-model-for-study-myocardial-performance-oxygen

Research

JoVE Journal

Biology

20.1K Views.  Boston Children’s Hospital. Isolated working heart models can be used to measure the effect of loading conditions, heart rate, and medications on myocardial performance and oxygen consumption. We describe methods for preparation of a rodent left heart working model that permits study of systolic and diastolic performance and oxygen consumption under various conditions.

Video: Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption

Assessment of Cardiac Function and Energetics in Isolated Mouse Hearts Using 31P NMR Spectroscopy

Bioengineered mouse models have become powerful research tools in determining causal relationships between molecular alterations and models of cardiovascular disease. Although molecular biology is necessary in identifying key changes in the signaling pathway, it is not a surrogate for functional significance. While physiology can provide answers to the question of function, combining physiology with biochemical assessment of metabolites in the intact, beating heart allows for a complete picture of cardiac function and energetics. For years, our laboratory has utilized isolated heart perfusions combined with nuclear magnetic resonance (NMR) spectroscopy to accomplish this task. Left ventricular function is assessed by Langendorff-mode isolated heart perfusions while cardiac energetics is measured by performing 31P magnetic resonance spectroscopy of the perfused hearts. With these techniques, indices of cardiac function in combination with levels of phosphocreatine and ATP can be measured simultaneously in beating hearts. Furthermore, these parameters can be monitored while physiologic or pathologic stressors are instituted. For example, ischemia/reperfusion or high workload challenge protocols can be adopted. The use of aortic banding or other models of cardiac pathology are apt as well. Regardless of the variants within the protocol, the functional and energetic significance of molecular modifications of transgenic mouse models can be adequately described, leading to new insights into the associated enzymatic and metabolic pathways. Therefore, 31P NMR spectroscopy in the isolated perfused heart is a valuable research technique in animal models of cardiovascular disease.

Assessment of Cardiac Function and Energetics in Isolated Mouse Hearts Using 31P NMR Spectroscopy

Langendorff-mode isolated heart perfusion, in conjunction with 31P NMR spectroscopy, combines the fields of biochemistry and physiology into one experiment. The protocol allows for the dynamic measurement of high energy phosphate content and turnover in the heart while concurrently monitoring physiologic function. When performed correctly, this is a valuable technique in the assessment of cardiac energetics.

Bioengineered mouse models have become powerful research tools in determining causal relationships between molecular alterations and models of ...

Medicine

NADH Fluorescence Imaging of Isolated Biventricular Working Rabbit Hearts

Since its inception by Langendorff1, the isolated perfused heart remains a prominent tool for studying cardiac physiology2. However, it is not well-suited for studies of cardiac metabolism, which require the heart to perform work within the context of physiologic preload and afterload pressures. Neely introduced modifications to the Langendorff technique to establish appropriate left ventricular (LV) preload and afterload pressures3. The model is known as the isolated LV working heart model and has been used extensively to study LV performance and metabolism4-6. This model, however, does not provide a properly loaded right ventricle (RV). Demmy et al. first reported a biventricular model as a modification of the LV working heart model7, 8. They found that stroke volume, cardiac output, and pressure development improved in hearts converted from working LV mode to biventricular working mode8. A properly loaded RV also diminishes abnormal pressure gradients across the septum to improve septal function. Biventricular working hearts have been shown to maintain aortic output, pulmonary flow, mean aortic pressure, heart rate, and myocardial ATP levels for up to 3 hours8.
When studying the metabolic effects of myocardial injury, such as ischemia, it is often necessary to identify the location of the affected tissue. This can be done by imaging the fluorescence of NADH (the reduced form of nicotinamide adenine dinucleotide)9-11, a coenzyme found in large quantities in the mitochondria. NADH fluorescence (fNADH) displays a near linearly inverse relationship with local oxygen concentration12 and provides a measure of mitochondrial redox state13. fNADH imaging during hypoxic and ischemic conditions has been used as a dye-free method to identify hypoxic regions14, 15 and to monitor the progression of hypoxic conditions over time10.
The objective of the method is to monitor the mitochondrial redox state of biventricular working hearts during protocols that alter the rate of myocyte metabolism or induce hypoxia or create a combination of the two. Hearts from New Zealand white rabbits were connected to a biventricular working heart system (Hugo Sachs Elektronik) and perfused with modified Krebs-Henseleit solution16 at 37 &deg;C. Aortic, LV, pulmonary artery, and left &amp; right atrial pressures were recorded. Electrical activity was measured using a monophasic action potential electrode. To image fNADH, light from a mercury lamp was filtered (350&plusmn;25 nm) and used to illuminate the epicardium. Emitted light was filtered (460&plusmn;20 nm) and imaged using a CCD camera. Changes in the epicardial fNADH of biventricular working hearts during different pacing rates are presented. The combination of the heart model and fNADH imaging provides a new and valuable experimental tool for studying acute cardiac pathologies within the context of realistic physiological conditions.

The objective is to monitor the mitochondrial redox state of isolated hearts within the context of physiologic preload and afterload pressures. A biventricular working rabbit heart model is presented. High spatiotemporal resolution fluorescence imaging of NADH is used to monitor the mitochondrial redox state of epicardial tissue.

Since its inception by Langendorff1, the isolated perfused heart remains a prominent tool for studying cardiac physiology2. However, it is not well-suited ...

An Isolated Working Heart System for Large Animal Models

Since its introduction in the late 19th century, the Langendorff isolated heart perfusion apparatus, and the subsequent development of the working heart model, have been invaluable tools for studying cardiovascular function and disease1-15. Although the Langendorff heart preparation can be used for any mammalian heart, most studies involving this apparatus use small animal models (e.g., mouse, rat, and rabbit) due to the increased complexity of systems for larger mammals1,3,11. One major difficulty is ensuring a constant coronary perfusion pressure over a range of different heart sizes &#8211; a key component of any experiment utilizing this device1,11. By replacing the classic hydrostatic afterload column with a centrifugal pump, the Langendorff working heart apparatus described below allows for easy adjustment and tight regulation of perfusion pressures, meaning the same set-up can be used for various species or heart sizes. Furthermore, this configuration can also seamlessly switch between constant pressure or constant flow during reperfusion, depending on the user&#8217;s preferences. The open nature of this setup, despite making temperature regulation more difficult than other designs, allows for easy collection of effluent and ventricular pressure-volume data.

Most studies involving the Langendorff apparatus use small animal models due to the increased complexity of systems for larger mammals. We describe a Langendorff system for large animal models that allows for use across a range of species, including humans, and relatively easy data acquisition.

Since its introduction in the late 19th century, the Langendorff isolated heart perfusion apparatus, and the subsequent development of the working heart ...

Pre-clinical Model of Cardiac Donation after Circulatory Death

Cardiac transplantation demand is on the rise; nevertheless, organ availability is limited due to a paucity of suitable donors. Organ donation after circulatory death (DCD) is a solution to address this limited availability, but due to a period of prolonged warm ischemia and the risk of tissue injury, its routine use in cardiac transplantation is seldom seen. In this manuscript we provide a detailed protocol closely mimicking current clinical practices in the context of DCD with continuous monitoring of heart function, allowing for the evaluation of novel cardioprotective strategies and interventions to decrease ischemia-reperfusion injury.
In this model, the DCD protocol is initiated in anesthetized Lewis rats by stopping ventilation to induce circulatory death. When systolic blood pressure drops below 30 mmHg, the warm ischemic time is initiated. After a pre-set warm ischemic period, hearts are flushed with a normothermic cardioplegic solution, procured, and mounted onto a Langendorff ex vivo heart perfusion system. Following 10 min of initial reperfusion and stabilization, cardiac reconditioning is continuously evaluated for 60 min using intraventricular pressure monitoring. A heart injury is assessed by measuring cardiac troponin T and the infarct size is quantified by histological staining. The warm ischemic time can be modulated and tailored to develop the desired amount of structural and functional damage. This simple protocol allows for the evaluation of different cardioprotective conditioning strategies introduced at the moment of cardioplegia, initial reperfusion and/or during ex vivo perfusion. Findings obtained from this protocol can be reproduced in large models, facilitating clinical translation.

This protocol shows a simple and flexible approach for the evaluation of new conditioning agents or strategies to increase the feasibility of cardiac donation after circulatory death.

Cardiac transplantation demand is on the rise; nevertheless, organ availability is limited due to a paucity of suitable donors. Organ donation after ...

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts

Small animal models are most commonly used in cardiovascular research due to the availability of genetically modified species and lower cost compared to larger animals. Yet, larger mammals are better suited for translational research questions related to normal cardiac physiology, pathophysiology, and preclinical testing of therapeutic agents. To overcome the technical barriers associated with employing a larger animal model in cardiac research, we describe an approach to measure physiological parameters in an isolated, Langendorff-perfused piglet heart. This approach combines two powerful experimental tools to evaluate the state of the heart: electrophysiology (EP) study and simultaneous optical mapping of transmembrane voltage and intracellular calcium using parameter sensitive dyes (RH237, Rhod2-AM). The described methodologies are well suited for translational studies investigating the cardiac conduction system, alterations in action potential morphology, calcium handling, excitation-contraction coupling and the incidence of cardiac alternans or arrhythmias.

The objective of this study was to establish a method for investigating cardiac dynamics using a translational animal model. The described experimental approach incorporates dual-emission optocardiography in conjunction with an electrophysiological study to assess electrical activity in an isolated, intact porcine heart model.

Small animal models are most commonly used in cardiovascular research due to the availability of genetically modified species and lower cost compared to ...

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Myocardial infarction (MI) remains the main contributor to morbidity and mortality worldwide. Therefore, research on this topic is mandatory. An easily and highly reproducible MI induction procedure is required to obtain further insight and better understanding of the underlying pathological changes. This procedure can also be used to evaluate the effects or potency of new and promising treatments (as drugs or interventions) in acute MI, subsequent remodeling and heart failure (HF). After intubation and pre-operative preparation of the animal, an anesthetic protocol with isoflurane was performed, and the surgical procedure was conducted&#160;quickly. Using a minimally invasive approach, the left anterior descending artery (LAD) was located and occluded by a ligature. The occlusion can be performed acutely for subsequent reperfusion (ischemia/reperfusion injury). Alternatively, the vessel can be ligated permanently to investigate the development of chronic MI, remodeling or HF. Despite common pitfalls, the drop-out rates are minimal. Various treatments such as remote ischemic conditioning can be examined for their cardioprotective potential pre-, peri- and post-operatively. The post-operative recovery was quick as the anesthesia was precisely controlled and the duration of the operation was short. Post-operative analgesia was administered for three days. The minimally invasive procedure reduces the risk of infection and inflammation. Furthermore, it facilitates rapid recovery. The &#8220;working heart&#8221; measurements were performed ex vivo and enabled precise control of preload, afterload and flow. This procedure requires specific equipment and training for adequate performance. This manuscript provides a detailed step-by-step introduction for conducting these measurements.

This article presents an efficient method to perform myocardial ischemia and subsequent chronic reperfusion in rats using a minimally invasive approach. In addition, left ventricular hemodynamic function of rats is assessed by echocardiography and isolated working heart methods.&#160;

Myocardial infarction (MI) remains the main contributor to morbidity and mortality worldwide. Therefore, research on this topic is mandatory. An easily ...

A New Model of Heart Failure Post-Myocardial Infarction in the Rat

Ligation of the left anterior descending (LAD) coronary artery has been widely used to establish the rat model of heart failure (HF) post myocardial infarction (MI). However, the disadvantages of this model include high mortality rate after ligation and larger variations both in the infarct size and the degree of impaired cardiac function. In addition, a ventilator or exteriorization of the heart is indispensable for the previous models, which complicates the procedure during the ligation. In this study, we developed a reliable and reproducible model without the ventilator or exteriorization of the heart by ligating the LAD coronary artery. Four weeks after the procedure, we found that the serum concentrations of CK-MB, NT-proBNP, and Renin, which were used to assist diagnoses of MI and HF, were significantly higher in the MI group compared to the sham group. In contrast, the value of left ventricle ejection fraction (LVEF) in the MI group was obviously less than in the sham group. Furthermore, the infarct size and cardiac fibrosis area were individually confirmed and quantitatively analyzed by TTC staining and Masson's trichrome staining. Smaller variations were found in either infarct size or fibrosis area in the MI group, which helped to develop a reliable and reproducible model of HF post-MI. This new model of HF post-MI in the rat is vital for studying the potential mechanisms of MI and HF. This new method can be used to develop the new drug for treatment of MI and HF in rats by using pharmacological strategies.

We successfully developed a reliable and reproducible model of heart failure post-myocardial infarction in the rat without ventilation or exteriorization of the heart. This simplifies the procedure and benefits the further studies about the potential mechanisms behind the heart failure.

Ligation of the left anterior descending (LAD) coronary artery has been widely used to establish the rat model of heart failure (HF) post myocardial ...

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Myocardial ischemia and reperfusion injury (MIRI), induced by coronary heart disease (CHD), causes damage to the cardiomyocytes. Furthermore, evidence suggests that thrombolytic therapy or primary percutaneous coronary intervention (PPCI) does not prevent reperfusion injury. There is still no ideal animal model for MIRI. This study aims to improve the MIRI model in rats to make surgery easier and more feasible. A unique method for establishing MIRI is developed by using a soft tube during a key step of the ischemic period. To explore this method, thirty rats were randomly divided into three groups: sham group (n = 10); experimental model group (n = 10); and existing model group (n = 10). Findings of triphenyltetrazolium chloride staining, electrocardiography, and percent survival are compared to determine the accuracies and survival rates of the operations. Based on the study results, it has been concluded that the improved surgery method is associated with a higher survival rate, elevated ST-T segment, and larger infarct size, which is expected to mimic the pathology of MIRI better.

Myocardial ischemia-reperfusion model of rat heart is improved by using a self-made retractor, polyvinyl chloride tube, and a unique knotting method. Electrocardiogram, triphenyltetrazolium chloride and histological staining, and percent survival analysis results showed that the improved model group has higher success and survival rates than the already existing model group.

Myocardial ischemia and reperfusion injury (MIRI), induced by coronary heart disease (CHD), causes damage to the cardiomyocytes. Furthermore, evidence ...

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart

The mammalian heart is a major consumer of ATP and requires a constant supply of energy substrates for contraction. Not surprisingly, alterations of myocardial metabolism have been linked to the development of contractile dysfunction and heart failure. Therefore, unraveling the link between metabolism and contraction should shed light on some of the mechanisms governing cardiac adaptation or maladaptation in disease states. The isolated working rat heart preparation can be used to follow, simultaneously and in real time, cardiac contractile function and flux of energy providing substrates into oxidative metabolic pathways. The present protocol aims to provide a detailed description of the methods used in the preparation and utilization of buffers for the quantitative measurement of the rates of oxidation for glucose and fatty acids, the main energy providing substrates of the heart. The methods used for sample analysis and data interpretation are also discussed. In brief, the technique is based on the supply of 14C- radiolabeled glucose and a 3H- radiolabeled long-chain fatty acid to an ex vivo beating heart via normothermic crystalloid perfusion. 14CO2 and 3H2O, end byproducts of the enzymatic reactions involved in the utilization of these energy providing substrates, are then quantitatively recovered from the coronary effluent. With knowledge of the specific activity of the radiolabeled substrates used, it is then possible to individually quantitate the flux of glucose and fatty acid in the oxidation pathways. Contractile function of the isolated heart can be determined in parallel with the appropriate recording equipment and directly correlated to metabolic flux values. The technique is extremely useful to study the metabolism/contraction relationship in response to various stress conditions such as alterations in pre and after load and ischemia, a drug or a circulating factor, or following the alteration in the expression of a gene product.

The following protocol describes the preparation and utilization of buffers for the quantitative measurement of rates of glucose and fatty acid oxidation in the isolated working rat heart. The methods used for sample analysis and data interpretation are also discussed.

The mammalian heart is a major consumer of ATP and requires a constant supply of energy substrates for contraction. Not surprisingly, alterations of ...

Optimization of Donor Heart Preservation Using a Working Rat Heart Perfusion Model

Using an Isolated Working Rat Heart Model to Test Donor Heart Preservation Strategies

Optimization of donor heart preservation solutions has played a key role in reducing ischemia-reperfusion injury in donor hearts during organ retrieval, transportation, and transplantation. Previous work from our laboratory showed that the addition of glyceryl trinitrate and erythropoietin to donor heart preservation solutions could significantly improve cardiac functional recovery after prolonged cold storage and in donation after circulatory death hearts. This supplementation protocol has been implemented in clinical use in transplant units around Australia, Belgium, and the United Kingdom. Here, we outline a protocol for testing supplementation strategies using an ex vivo isolated working rat heart (IWRH) perfusion circuit. Using this methodology, supplementation strategies can be tested in the context of prolonged cold static storage, donation after brain death, and donation after circulatory death donor heart preservation. Cardiac functional recovery, measured by aortic flow, coronary flow, cardiac output, pulse pressure, and heart rate, can be used to determine whether a particular preservation strategy can minimize ischemia-reperfusion injury of the donor heart.

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies

We describe an ex vivo isolated working rat heart protocol to test donor heart preservation strategies. This paper describes the protocol for use in static cold storage of rodent donor hearts; however, the protocol can also be used for donor hearts obtained after donation after circulatory death and brain death.

Optimization of donor heart preservation solutions has played a key role in reducing ischemia-reperfusion injury in donor hearts during organ retrieval, ...

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption

Samenvatting

Meer video's verkennen